Certain statements in this Report constitute "forward-looking statements." Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results, performance or achievements to
be materially different from any future results, performance or achievements
expressed or implied by such forward-looking statements. Factors that might
cause such a differences include, among others, uncertainties relating to
general economic and business conditions; industry trends; changes in demand for
our products and services; uncertainties relating to customer plans and
commitments and the timing of orders received from customers; announcements or
changes in our pricing policies or that of our competitors; unanticipated delays
in the development, market acceptance or installation of our products and
services; changes in government regulations; availability of management and
other key personnel; availability, terms and deployment of capital;
relationships with third-party equipment suppliers; inflation, the war in
Ukraine, supply chain slowdowns, reoccurring Covid-19 outbreaks, both nationally
and internationally, particularly in China, and worldwide political stability
and economic growth. The words "believe," "expect," "anticipate," "hope,"
"intend" and "plan" and similar expressions identify forward-looking statements.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date the statement was made.



Results of Operations


Three Months Ended February 28, 2022 compared with the Three Months Ended February 28, 2021

The narrative comparison of results of operations for the three-month periods ended February 28, 2022 and 2021, is based on the following table.





                                                                 Three Months Ended
                                                A                  B               A-B              %
                                           February 28,       February 28,
                                               2022               2021            Change         Change
REVENUE                                   $       24,343     $       14,377     $    9,966              69 %
COST OF REVENUE                                   14,405             12,350          2,055              17 %

Cost of revenue as a % of total revenue               59 %               86 %          -27 %
Gross Profit                                       9,938              2,027          7,911             390 %
Gross profit as a % of revenue                        41 %               14 %           27 %
OPERATING EXPENSES
Officer and director compensation                203,785            135,000         68,785              51 %
General and administrative                        48,771             23,027         25,744             112 %
Professional fees and contract services           22,445            118,231        (95,786 )           -81 %
Advertising and promotion                         28,088                  -         28,088            n.a.
Total operating expenses                         303,089            276,258         26,831              10 %

OPERATING LOSS - CONTINUING OPERATIONS (293,151 ) (274,231 ) (18,920 )

             7 %




Revenues increased 69% in the quarter ended February 28, 2022 compared with the
same period in 2021. The increase in the current quarter was largely due to
direct sales efforts by our sales team. Management has remained focused on sales
efforts for the debudder products while also working to expand our relationship
with PPK Investment Group, Inc., a vertically integrated cannabis company
selling the Country Cannabis Brand of products, and seeking other acquisitions.
We anticipate that we will maintain a marketing focus on the debudder products
in the coming periods but also expect to devote substantial attention to our
efforts at growing our presence in the cannabis industry through acquisitions.
We recently entered into an agreement to acquire a facility and cannabis
licenses for an operation in Denver Colorado, and we expect to close on a an
acquisition of a facility and licenses in California in April or May of this
year. These acquisitions will have a significant effect on the direction of

our
future operations.



                                       2





As a percentage of sales, cost of sales decreased between periods as a result of
improved efficiencies in our fulfillment centers. In the prior period, we moved
our inventory to a new California fulfillment center and the costs of the move
impacted results in the three months ended February 28, 2021.



Total operating expenses increased somewhat in the current period primarily due
to increased expenditures for officer and director compensation resulting from
the addition of a fourth director and payment of comensation to that director.
General and administrative expenses increased in the current period compared
with a year earlier, primarily driven by travel expenses associated with the
Company's investment in PPK Investment Group, Inc., and other merger and
acquisition work performed during the current period. Advertising and promotion
also increased as a result of increased expenditures for investor awareness in
the current period. These increases were partially offset by a decrease in
professional fees. In the current period, costs previously categorized as
professional fees were reclassified as officer and director compensation when
one of our consultants accepted a position on the Board.



Net loss from continuing operations increased in 2022 compared with 2021 primarily due to increases in advertising and promotion expenses and consulting fees relating to the Company's investor relations efforts.

Nine Months Ended February 28, 2022 compared with the Nine Months Ended February 28, 2021

The narrative comparison of results of operations for the nine-month periods ended February 28, 2022 and 2021, is based on the following table.





                                                                 Nine Months Ended
                                                A                 B               A-B              %
                                          February 28,       February 28,
                                              2022               2021            Change         Change
REVENUE                                   $     147,395     $       87,513     $   59,882              68 %
COST OF REVENUE                                  50,774             42,484          8,290              20 %

Cost of revenue as a % of total revenue              34 %               49 %          -14 %
Gross Profit                                     96,621             45,029         51,592             115 %
Gross profit as a % of revenue                       66 %               51 %          -14 %
OPERATING EXPENSES
Officer and director compensation               542,570            400,000        142,570              36 %
General and administrative                      113,644             59,410         54,234              91 %
Professional fees and contract services         176,710            358,084       (181,374 )           -51 %
Advertising and promotion                       375,461                  -        375,461            n.a.
Total operating expenses                      1,208,385            817,494        390,891              48 %

OPERATING LOSS - CONTINUING OPERATIONS (1,111,764 ) (772,465 ) (339,299 )

            44 %




Revenues increased 68% in the nine-month period ended February 28, 2022 compared
with the same period in 2021. Management refocused sales efforts on the debudder
products after discontinuing operations of the soils business acquired from
Elevated Ag Solutions, Inc. ("Elevated") in early October 2020. The soils
division was discontinued in the quarter ended November 30, 2020 and is not
reflected in operating results for the periods presented above (see
"Discontinued Operations"). We anticipate that the marketing focus on the
debudder products will continue now that the soils division has been
discontinued. We also recently entered into an agreement to acquire a facility
and cannabis licenses for an operation in Denver Colorado, and we expect to
close on a an acquisition of a facility and licenses in California in April or
May. Management believes these acquisitions will have a significant effect on
the direction of our future operations.



                                       3





Total operating expenses increased in the current period, primarily due to
increased expenditures for advertising and promotion and increases in travel
related to an increased focus on acquisitions. In the nine-month period ended
February 28, 2022, we retained a consultant to communicate with prospective
funding sources, coordinate press releases, and in general assist with market
awareness of the company. The cost of this program was paid partially in cash
and partially in stock with an aggregate cost of $250,250. Additional
advertising expenses were incurred for trade show expenses in connection with
our attendance at the MJBIZCON trade show in Las Vegas. Officer and director
compensation increased and professional fees and contract services decreased in
2022 compared with 2021, primarily due to the appointment of one of our
contractors as a director in the current period and the associated
reclassification of his contract fees to "officer and director compensation."
General and administrative expenses increased in the current period compared
with a year earlier, primarily driven by travel expenses associated with the
Company's investment in PPK Investment Group, Inc.

Net loss from continuing operations increased in 2022 compared with 2021 primarily due to the increase in advertising and promotion expenses.





Non-Operating Expenses.



In the three and nine-month periods ended February 28, 2022, the Company
incurred $34,134 and $645,592, respectively, in interest and finance expense
relating to notes payable from a funding transaction on March 22, 2021. The
nine-month amount included $550,000 in discount on notes payable. The Company
had no comparable outstanding debt in the three and nine-month periods ended
February 28, 2021. The notes payable were due on March 22, 2022, subsequently
extended to March 29, 2022, and paid in full with accrued interest on March 29,
2022. The source of funds for the repayment of the notes was from a new senior
lender. The company expects to enter into a senor convertible debt agreement
with the new senior lender in our fiscal fourth quarter.



Discontinued Operations.



In the prior year, after operating the soils division for the first four months
of the year ended May 31, 2021, management undertook an in-depth assessment of
Elevated Ag Solutions, Inc. ("Elevated") and concluded that the soils division
was not as represented at the time of the acquisition in January 2020, was not
likely to ever operate profitably without significant revisions to operating
methods and changes in personnel and was likely to create significant business
questions and concerns should it be continued. Accordingly, management elected
to discontinue the business acquired from Elevated. Upon discontinuation of the
Elevated business, the Company entered into a settlement and unwinding agreement
with Elevated and returned all assets acquired in the transaction to Elevated.
During the nine months ended February 28, 2021, the common stock issued in the
acquisition, aggregating 1,300,000 shares out of 1,400,000 shares originally
issued, were cancelled, and the Company paid a $10,000 walk-away fee. In the
aggregate, the Company recognized a loss from discontinued operations of
$10,000.



Operating results for the three and nine-month periods ended February 28, 2021 from the discontinued operations are reflected in the following table.





                                  Three Month Period       Nine-Month Period
                                  Ended February 28,       Ended February 28,
                                         2021                     2021
Revenue                           $                 -     $             75,217
Cost of revenue                                     -                  (66,243 )
Amortization                                        -                  (13,125 )
Gross profit                                        -                   (4,151 )
Loss on discontinued operations                     -                   10,000
                                  $                 -     $            (14,151 )




                                       4




Liquidity and Capital Resources





Cash flow used in operating activities for the nine-month period ended February
28, 2022 was $329,212 compared with $175,329 in the comparable period in 2021.
During the period, our total cash decreased by $115,712. Cash to fund the
negative cash flow from operations was derived primarily from proceeds of
advances from related parties totaling $213,500.



The Company continues to make progress in growing sales of its existing product
line, but the business is not yet sufficient to support our current operating
structure. Our current working capital is negative $1,237,969, based on current
assets of $122,238 and current liabilities of $1,360,207. We continue to seek
out potential acquisition candidates and distributorships and hope to see
continuing growth in sales in the coming periods. The Company is currently
reliant on funding through advances from related parties, but we have no binding
agreements or commitments for such funding and no assurances can be given that
such funding will continue to be available in future periods.



The accompanying consolidated financial statements have been prepared assuming
that the Company will continue as a going concern, which contemplates the
realization of assets and the liquidation of liabilities in the normal course of
business.  We incurred net losses from continuing operations of $327,285 and
$1,757,356 for the three and nine-month periods ended February 28, 2022,
respectively, and had an accumulated deficit of $10,855,613 as of February 28,
2022. In addition, we have notes payable aggregating $900,000 plus accrued
interest that are due on March 22, 2022.  These factors raise substantial doubt
about the Company's ability to continue as a going concern.  The Company may
seek to raise money for working capital purposes through a public offering of
its equity capital or through a private placement of equity capital or
convertible debt.  It will be important for the Company to succeed in its
efforts to raise capital in this manner to further its business plan in an

aggressive manner.  Raising additional capital may cause dilution to current
shareholders.



COVID-19



We are now in the third year of the COVID-19 pandemic. While the impact of the
pandemic is lessening, new COVID variants are causing continued concern and the
pandemic is not over. To date, the disruption from COVID-19 did not materially
impact the Company's financial statements. However, if the severity of the
economic disruptions increase as the duration of the COVID-19 pandemic
continues, the negative financial impact due to reduced demand could be
significantly greater in future periods than in the third fiscal quarter ended
February 28, 2022.



The effects of the continued outbreak of COVID-19 and related government
responses may include extended disruptions to supply chains and capital markets,
reduced labor availability and a prolonged reduction in economic activity in our
industry. These effects could have a variety of adverse impacts to the Company,
including an inability to adequately staff and operate our facilities. To date,
there have been no material adverse impacts to the Company's operations due

to
COVID-19.



The economic disruptions caused by COVID-19 could also adversely impact
impairment risks for certain long-lived assets, equity method investments and
goodwill. Management evaluated these impairment considerations and determined
that no such impairments occurred through the date of this report.



Off Balance Sheet Arrangements

None

© Edgar Online, source Glimpses